Skip to content
The Nexus
DossierENTITY

Cancer drugs

Coverage of Cancer drugs in the Nexus archive.

Earliest in view: Apr 10 · 03:42 UTCMost recent: Jul 6 · 15:10 UTC
Co-mentioned in this coverage
Lokayuktaorganization1Karnataka governmentorganization1BET inhibitorstopic1BRD2topic1BRD4topic1Gene activationtopic1
Recent coverage
  • HEALTHJul 6 · 15:10 UTCTHE HINDU NATIONAL
    Lokayukta directs Karnataka govt. to act on cancer drug availability

    The Lokayukta has directed the Karnataka government to take action regarding the availability of cancer drugs.

  • HEALTHApr 10 · 03:42 UTCSCIENCE DAILY
    Scientists finally uncover why promising cancer drugs keep failing

    Scientists have identified why BET inhibitors, a class of cancer drugs, have failed in clinical trials. The research shows BRD2 and BRD4 proteins have distinct roles in gene activation, with BRD2 acting as a 'stage manager' and BRD4 triggering gene activation. Blocking both proteins simultaneously disrupts the process, leading to inconsistent drug effectiveness.